HealthTree Logo
search more_vert

Clinical Expertise

  • Bone marrow failure, hemolytic anemias, myelodysplastic syndromes


Dr. Elghetany has been studying the expression of the p53, p21 waf, WT-1, caspase-3, survivin, and Ki 67 in inherited and acquired bone marrow failure syndromes in an attempt to gain insight into the mechanism of cytopenias. Also, he is investigating the possible use of expression patterns to help differentiate inherited from acquired cytopenias. He continues to study patients with inherited bone marrow failure syndromes using cytochemistry and flow cytometry in order to find changes that could be predictive of the development of myelodysplastic syndrome or acute leukemia.



M.B.,B.Ch. from Ains Shams University
01/1979 - Cairo, Egypt


Texas Children's Cancer Center: 1102 Bates Ave, Houston, TX 77030, USA

Get the latest thought leadership on MDS delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for MDS Newsletter" for MDS news, life with MDS stories, MDS clinical trials, MDS 101 articles and events with MDS experts.